Mycophenolic Acid and Metabolites
Ordering Recommendation
Optimize drug therapy and monitor patient adherence.
New York DOH Approval Status
Specimen Required
Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.
Plain red. Also acceptable: Lavender (K2 or K3EDTA) or pink (K2EDTA).
Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.1 mL)
Refrigerated.
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).
After separation from cells: Ambient: 6 weeks; Refrigerated: 6 weeks; Frozen: 11 months
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days
Reference Interval
| Available Separately |
Component |
Therapeutic Range |
Toxic |
|---|---|---|---|
| No | Mycophenolic Acid | 1.0 - 3.5 µg/mL | Greater than 25.0 µg/mL |
| No | Mycophenolic Acid Glucuronide | 35.0-100.0 µg/mL | Not well established |
Interpretive Data
The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration. A proposed therapeutic range is 1.0-3.5 ug/mL for a 2 g/day dose. A 3 g/day dose may have plasma concentrations up to 5.0 ug/mL. Trough concentrations between 2.0 and 4.0 ug/mL have been suggested to maximize efficacy and minimize adverse effects. Mycophenolic acid glucuronide is an inactive metabolite and a range of 35.0-100.0 ug/mL indicates normal metabolism. During the first two weeks of transplantation, mycophenolic acid glucuronide concentrations are typically 100 - 250 ug/mL. Adverse effects of toxicity include abdominal pain, peripheral edema, cardiac abnormalities, hypertension and electrolyte disturbances.
Laboratory Developed Test (LDT)
Note
Hotline History
Hotline History
CPT Codes
80180
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0090213 | Mycophenolic Acid by HPLC-MS/MS | 55806-4 |
| 2010110 | Mycophenolic Acid Glucuronide | 55807-2 |
Aliases
- Cellcept
- CellCept MPA
- Myfortic
















